Plasma asymmetric dimethylarginine, l-arginine and left ventricular structure and function in a community-based sample

Atherosclerosis

Volumn 204, Issue 1, 2009, Pages 282-287

  Lieb, Wolfgang ^a   Benndorf, Ralf A ^b   Benjamin, Emelia J ^a,c   Sullivan, Lisa M ^a,d   Maas, Renke ^e   Xanthakis, Vanessa ^d   Schwedhelm, Edzard ^b   Aragam, Jayashri ^a,f   Schulze, Friedrich ^b   Böger, Rainer H ^b   Vasan, Ramachandran S ^a,c  

^a FRAMINGHAM HEART STUDY   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

ADMA; Biomarker; Epidemiology; Hypertrophy; l Arginine

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ARGININE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; CIRCULATION; COMMUNITY CARE; CONTROLLED STUDY; DIABETES MELLITUS; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE OVERLOAD; HEART SIZE; HORMONE SUBSTITUTION; HUMAN; HYPERLIPIDEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; OBESITY; PREVALENCE; PRIORITY JOURNAL; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; ARGININE; FEMALE; HEART ATRIA; HEART VENTRICLES; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL CONTRACTION; OBESITY; POPULATION SURVEILLANCE; RISK ASSESSMENT; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 67349251188     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.08.018     Document Type: Article

References (34)

1. Levy D., Garrison R.J., Savage D.D., Kannel W.B., and Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322 (1990) 1561-1566
2. Vasan R.S., Larson M.G., Levy D., Evans J.C., and Benjamin E.J. Distribution and categorization of echocardiographic measurements in relation to reference limits:The Framingham Heart Study:formulation of a height-and sex-specific classification and its prospective validation. Circulation 96 (1997) 1863-1873
3. Barouch L.A., Harrison R.W., Skaf M.W., et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416 (2002) 337-339
4. Massion P.B., Feron O., Dessy C., and Balligand J.L. Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 93 (2003) 388-398
5. Yetik-Anacak G., and Catravas J.D. Nitric oxide and the endothelium: history and impact on cardiovascular disease. Vasc Pharmacol 45 (2006) 268-276
6. Barouch L.A., Cappola T.P., Harrison R.W., et al. Combined loss of neuronal and endothelial nitric oxide synthase causes premature mortality and age-related hypertrophic cardiac remodeling in mice. J Mol Cell Cardiol 35 (2003) 637-644
7. Ichinose F., Bloch K.D., Wu J.C., et al. Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency. Am J Physiol Heart Circ Physiol 286 (2004) H1070-H1075
8. Ozaki M., Kawashima S., Yamashita T., et al. Overexpression of endothelial nitric oxide synthase attenuates cardiac hypertrophy induced by chronic isoproterenol infusion. Circ J 66 (2002) 851-856
9. Boger R.H. Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med 38 (2006) 126-136
10. Zoccali C., Mallamaci F., Maas R., et al. Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients. Kidney Int 62 (2002) 339-345
11. Kannel W.B., Feinleib M., McNamara P.M., Garrison R.J., and Castelli W.P. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 110 (1979) 281-290
12. Savage D.D., Garrison R.J., Kannel W.B., et al. Considerations in the use of echocardiography in epidemiology. The Framingham Study. Hypertension 9 (1987) II40-II44
13. Devereux R.B., Alonso D.R., Lutas E.M., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
14. Schwedhelm E., Maas R., Tan-Andresen J., et al. High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma. J Chromatogr B Anal Technol Biomed Life Sci 851 (2007) 211-219
15. Massion P.B., and Balligand J.L. Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice. J Physiol 546 (2003) 63-75
16. Belge C., Massion P.B., Pelat M., and Balligand J.L. Nitric oxide and the heart: update on new paradigms. Ann NY Acad Sci 1047 (2005) 173-182
17. Bloch K.D., and Janssens S. Cardiomyocyte-specific overexpression of nitric oxide synthase 3: impact on left ventricular function and myocardial infarction. Trends Cardiovasc Med 15 (2005) 249-253
18. Schnabel R., Blankenberg S., Lubos E., et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res 97 (2005) e53-e59
19. Zoccali C., Bode-Boger S., Mallamaci F., et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358 (2001) 2113-2117
20. Nijveldt R.J., Teerlink T., Van Der H.B., et al. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr 22 (2003) 23-30
21. Busse R., Edwards G., Feletou M., et al. EDHF: bringing the concepts together. Trends Pharmacol Sci 23 (2002) 374-380
22. Collins A.J., Li S., Gilbertson D.T., et al. Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl (2003) S24-S31
23. Kizer J.R., Bella J.N., Palmieri V., et al. Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am Heart J 151 (2006) 412-418
24. Vasan R.S. Cardiac function and obesity. Heart 89 (2003) 1127-1129
25. Gottdiener J.S., Reda D.J., Williams D.W., and Materson B.J. Left atrial size in hypertensive men: influence of obesity, race and age. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. J Am Coll Cardiol 29 (1997) 651-658
26. Fischer M., Baessler A., Hense H.W., et al. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 24 (2003) 320-328
27. Kenchaiah S., Evans J.C., Levy D., et al. Obesity and the risk of heart failure. N Engl J Med 347 (2002) 305-313
28. Eid H.M., Arnesen H., Hjerkinn E.M., Lyberg T., and Seljeflot I. Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. Metabolism 53 (2004) 1574-1579
29. Cooke J.P. Asymmetrical dimethylarginine: the Uber marker?. Circulation 109 (2004) 1813-1818
30. Keaney Jr. J.F., Larson M.G., Vasan R.S., et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 23 (2003) 434-439
31. Himmelfarb J., Stenvinkel P., Ikizler T.A., and Hakim R.M. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62 (2002) 1524-1538
32. Boger R.H., and Ron E.S. l-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor. Altern Med Rev 10 (2005) 14-23
33. Jiang J.L., Zhu H.Q., Chen Z., Xu H.Y., and Li Y.J. Angiotensin-converting enzyme inhibitors prevent LDL-induced endothelial dysfunction by reduction of asymmetric dimethylarginine level. Int J Cardiol 101 (2005) 153-155
34. Heutling D., Schulz H., Nickel I., et al. Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment. J Clin Endocrinol Metab 93 (2008) 82-90